Characteristics Associated With Duration of Home Hospitalization in Internal Department Versus Hospitalization in the Hospital in Internal Ward
NCT ID: NCT06049875
Last Updated: 2023-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2023-07-02
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Around the world, more and more experience is being accumulated in operating home hospitalizations as a substitute for hospitalization in a hospital. Comparative studies in diverse populations showed, already 20 years ago, that hospitalization at home is preferable to hospitalization in a hospital when it comes to the quality of life in a supportive and familiar environment \[7\]. However, the issue of the economic viability of home hospitalizations, whose cost was higher in the past, remains under question. There are studies that show a decrease in the cost of treatment in the home environment even in complex treatments and by professional teams \[8\]. Technological developments in the field of remote medicine have greatly contributed to improving the quality of care provided at home. Today, medical technology allows a patient who has been discharged from the hospital to be hospitalized at home, which allows the patient to continue to be treated at home through close medical and nursing supervision and advanced technological equipment. The technological development also allows cost reduction in different clinical settings such as: patients suffering from a flare-up of obstructive pulmonary disease \[10,9\], patients who are transferred to home hospitalization after surgery, elderly patients suffering from chronic diseases and needing hospitalization due to pneumonia and soft tissue infections, and patients suffering from exacerbation of heart failure \[11\]. The Ministry of Health and Welfare in the United States estimates that in 2030 one out of 5 Americans will be over the age of 65 and that home hospitalization is the preferred way to provide care to the patient as well as the optimal way in terms of costs \[12\]. This phenomenon will intensify the need for home hospitalization and will lead to improvements in the home sector \[13\].
At the Haim Sheba Tertiary Medical Center, they combine unique capabilities that make it particularly suitable for launching a home hospitalization service. The internal departments of the medical center are experienced in managing complex patients. The management of the departments is based on experts in internal medicine who have extensive experience in specializing in In the management of complex cases, with a high turnover of patients with mild and moderate degrees of severity, the hospital's position also matches the position of the relevant professional body - the Israeli Association of Internal Medicine - in regards to the launch of home hospitalization.
A center for innovation in digital health was established in Sheba, the purpose of which is to test and implement advanced technologies of remote medicine. Examining and operating these technologies, while having a unique collaboration with the companies that develop and manufacture them, places the innovation in an excellent opening position in terms of the ability to evaluate and operate the existing technologies in the hands of the doctors in the medical center.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mortality and Rehospitalization Risk Assessment by Skilled Caregivers Compared to Existing Tools in Acute Geriatric Departments
NCT06675084
Association Between Early Consultation by the Primary Care Physician After Hospitalization in Geriatric Medicine Department, and the Risk of Re-hospitalization at 1 and 3 Months
NCT07056153
Mortality Risk Assessment by Skilled Staff Compared to Existing Validated Tools in Skilled Nursing Departments
NCT06675071
Hospital at Home Versus Inpatient Care: Costs and Effectiveness
NCT07274072
The Hospice Advanced Dementia Symptom Management and Quality of Life Trial
NCT03681119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Characterization, establishment and operation of a home hospitalization program managed by a hybrid division.
The target population is all patients who come from the community to the hospital's emergency room in Israel, who come to the emergency room for hybrid home hospitalization or hospitalization in an internal hospital department. The population accessible to the study is patients aged 18 and over who come to the emergency room for treatment and meet the inclusion criteria.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Home Hospitalization
Patients who arrived at the emergency department and were discharged to home hospitalization or were hospitalized for a day and discharged to comprehensive home hospitalization under the management of a remote internist and a nurse who will make home visits on a daily basis.
No interventions assigned to this group
Internal Ward Hospitalization
Patients who arrived at the emergency department and received a regular treatment.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Respiratory infections in a patient who does not suffer from immunodeficiency
* Infection of the urinary tract in a patient who does not suffer from immunodeficiency
* Soft tissue infection of the lower limbs in a patient who does not suffer from immunodeficiency
* Flare-up of chronic obstructive pulmonary disease in a patient who does not demonstrate respiratory failure in the emergency department
* Infection of the upper/lower digestive tract in a patient who does not suffer from immunodeficiency
* Starting the investigation of a prolonged febrile illness of unknown origin in a patient who does not suffer from immunodeficiency
* Flare-up of heart failure in a respiratory and hemodynamically stable patient - including hypoxemia
Exclusion Criteria
* Patients who came to the emergency department with delirium
* Patients who do not have the appropriate conditions for home hospitalization - terminally ill, lack of family support, and lack of ability to operate technologies in a home setting
* Patients with hemodynamic, respiratory or neurological instability.
* Patients whose treatment requires the use of measures or drugs that cannot be provided in a hospital setting
* Unbalanced psychiatric patients
* Patients who live within a radius of more than 50 km from Sheba Hospital (according to the procedure of the Ministry of Health)
* Patients who are not interested in home hospitalization / or who were hospitalized during home hospitalization
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Gad Segal
prof.Gad.Segal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Difference between tow independent mean -tow groups
Ramat Gan, , Israel
Sheba Medical Center
Ramat Gan, , Israel
Daniella Daliyot
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sheba 0096 GS 2023 CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.